Question: is a parp inhibitor chemotherapy?
Answer: A PARP inhibitor used in combination with chemotherapy for first-line and maintenance treatment significantly improved progression-free survival (PFS) in stage III or IV high-grade serous ovarian cancer, according to new results from a Phase III trial.